We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

DLXY:NASDAQDelixy Holdings Limited Analysis

Data as of 2026-03-29 - not real-time

$0.62

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Delixy Holdings is trading at $0.62, well below its 20‑day (0.83) and 50‑day (0.87) simple moving averages, with a bearish MACD and an RSI of 40.6 indicating limited upward momentum. The stock’s 30‑day volatility exceeds 200% and volume is on a downtrend, underscoring a fragile market structure. DCF analysis places fair value at $0.70, suggesting a modest upside relative to the current price, but the company’s fundamentals are weak: revenue fell 29%, gross margin is a meager 1.3%, and free cash flow is negative $1.45 M. Leverage is extreme, with a debt‑to‑equity ratio above 200% and a max drawdown of –92%, while the PE of 8.9 is well under the industry average of 24, reflecting earnings that are barely sustainable.
A recent 158% after‑hours surge tied to potential Strait of Hormuz disruptions highlights the stock’s sensitivity to geopolitical events, but the underlying financial health remains precarious. Given the combination of bearish technical signals, high volatility, thin margins, and substantial debt, the investment case is highly speculative despite a nominal valuation gap.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 8/10

Key Factors

  • Price below key moving averages and bearish MACD
  • Extreme 30‑day volatility and decreasing volume
  • Negative free cash flow and high debt‑to‑equity

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • DCF fair value modestly above current price
  • Potential upside if oil‑supply disruptions improve margins
  • Continued earnings weakness and leverage concerns

Long Term

> 3 years
Neutral
Model confidence: 4/10

Key Factors

  • Fundamental restructuring needed to improve profitability
  • Geopolitical exposure to Middle‑East oil routes
  • Low beta suggests limited market‑wide correlation but high company‑specific risk

Key Metrics & Analysis

Financial Health

Revenue Growth-29.00%
Profit Margin0.42%
P/E Ratio8.8
ROE84.67%
ROA3.26%
Debt/Equity211.08
P/B Ratio4.8
Op. Cash Flow$1.4M
Free Cash Flow$-1451750
Industry P/E24.0

Technical Analysis

TrendBearish
RSI40.6
Support$0.51
Resistance$1.64
MA 20$0.83
MA 50$0.87
MA 200$2.26
MACDBearish
VolumeDecreasing
Fear & Greed Index65.98

Valuation

Fair Value$0.70
GradeUndervalued
TypeValue

Risk Assessment

Beta0.58
Volatility213.82%
Sector RiskHigh
Reg. RiskMedium
Geo RiskHigh
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.